Paper21773005
Rimonabant: From RIO to Ban.
Sam AH and 2 others. J Obes, 2011. Cited by 185 papers, by iCite.
Cite this record
ConductScience Library. Rimonabant: From RIO to Ban. Papers, record 21773005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21773005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0701371 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20664173 | Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20664173 | PubMed |
| 2 | 17098084 | Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. | Lancet | 2006 | https://conductscience.org/library/papers/17098084 | PubMed |
| 3 | 7689702 | Molecular characterization of a peripheral receptor for cannabinoids. | Nature | 1993 | https://conductscience.org/library/papers/7689702 | PubMed |
| 4 | 15784668 | A potential decline in life expectancy in the United States in the 21st century. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15784668 | PubMed |
| 5 | 11298451 | Leptin-regulated endocannabinoids are involved in maintaining food intake. | Nature | 2001 | https://conductscience.org/library/papers/11298451 | PubMed |
| 6 | 15836887 | Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. | Lancet | 2005 | https://conductscience.org/library/papers/15836887 | PubMed |
| 7 | 12451119 | Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. | J Neurosci | 2002 | https://conductscience.org/library/papers/12451119 | PubMed |
| 8 | 18678611 | SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. | Diabetes Care | 2008 | https://conductscience.org/library/papers/18678611 | PubMed |
| 9 | 9080435 | Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. | Neuroreport | 1997 | https://conductscience.org/library/papers/9080435 | PubMed |
| 10 | 20818901 | Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20818901 | PubMed |
| 11 | 12669182 | Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. | Psychopharmacology (Berl) | 2003 | https://conductscience.org/library/papers/12669182 | PubMed |
| 12 | 16140402 | Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. | Behav Brain Res | 2005 | https://conductscience.org/library/papers/16140402 | PubMed |
| 13 | 18022033 | Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. | Lancet | 2007 | https://conductscience.org/library/papers/18022033 | PubMed |
| 14 | 17054276 | Rimonabant for overweight or obesity. | Cochrane Database Syst Rev | 2006 | https://conductscience.org/library/papers/17054276 | PubMed |
| 15 | 16291982 | Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16291982 | PubMed |
| 16 | 12897210 | The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12897210 | PubMed |
| 17 | 18719634 | Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. | Obesity (Silver Spring) | 2008 | https://conductscience.org/library/papers/18719634 | PubMed |
| 18 | 16478899 | Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. | JAMA | 2006 | https://conductscience.org/library/papers/16478899 | PubMed |
Cited by120
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42965085 | Discovery of a Peripherally Directed CB1 Receptor Antagonist That Restores Insulin Signaling in Adipocytes. | ACS Omega | 2026 | https://conductscience.org/library/papers/42965085 | PubMed |
| 42650836 | Endogenous Lipid Signals in Energy Homeostasis and Fibrosis. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650836 | PubMed |
| 42572649 | Emerging roles of cannabinoid pathways in renal injury and repair. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42572649 | PubMed |
| 42422426 | Adipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42422426 | PubMed |
| 42352627 | The Neural Network of Orexin-A: Implications in Feeding Regulation and Obesity-Anxiety Comorbidity. | Brain Sci | 2026 | https://conductscience.org/library/papers/42352627 | PubMed |
| 42239616 | An analysis on the role of glucagon-like peptide 1 receptor agonists in cognitive and mental health disorders. | Nat Ment Health | 2025 | https://conductscience.org/library/papers/42239616 | PubMed |
| 42004545 | Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42004545 | PubMed |
| 41965364 | Not only gut feelings: pancreatic hormone, amylin, controls emotionality and sociability, in a sex divergent manner. | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/41965364 | PubMed |
| 41850718 | Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study. | BMJ Open Diabetes Res Care | 2026 | https://conductscience.org/library/papers/41850718 | PubMed |
| 41750191 | Multiple Roles of Cannabinoids in the Olfactory System. | Brain Sci | 2026 | https://conductscience.org/library/papers/41750191 | PubMed |
| 41608471 | The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41608471 | PubMed |
| 41381865 | Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/41381865 | PubMed |
| 41016636 | Leptin and G-protein coupled receptor (GPCR) signaling: Therapeutic potential in obesity. | J Biol Chem | 2025 | https://conductscience.org/library/papers/41016636 | PubMed |
| 40969876 | Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in Cancer. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40969876 | PubMed |
| 40822483 | Barriers to glucagon-like peptide-1 agonists used for obesity management among the general population in Tabuk City, Saudi Arabia, and their relation to smoking cessation and antidepressants. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40822483 | PubMed |
| 40631457 | Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning. | Diabetes Metab J | 2025 | https://conductscience.org/library/papers/40631457 | PubMed |
| 40400441 | Effects of 28-day simvastatin administration on emotional processing, reward learning, working memory, and salivary cortisol in healthy participants at-risk for depression: OxSTEP, an online experimental medicine trial. | Psychol Med | 2025 | https://conductscience.org/library/papers/40400441 | PubMed |
| 40341983 | Cannabis, Weight, and Weight-Related Behaviors. | Curr Obes Rep | 2025 | https://conductscience.org/library/papers/40341983 | PubMed |
| 40034365 | A systematic study of molecular targets of cannabidiol in Alzheimer's disease. | J Alzheimers Dis Rep | 2024 | https://conductscience.org/library/papers/40034365 | PubMed |
| 39869298 | Impact of CB1 receptor antagonism on skeletal muscle hypertrophy and metabolic health: a systematic review of preclinical studies. | Hormones (Athens) | 2025 | https://conductscience.org/library/papers/39869298 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADIPOQ | 9370 | PubTator's text mining | https://conductscience.org/library/genes/9370 | NCBI Gene |
| CNR1 | 1268 | PubTator's text mining | https://conductscience.org/library/genes/1268 | NCBI Gene |
| CNR2 | 1269 | PubTator's text mining | https://conductscience.org/library/genes/1269 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21773005
GET https://conductscience.org/api/papers/v1/21773005/cited_by?page=2